Literature DB >> 3933333

Aluminum accumulation in individuals with normal renal function.

S M Ott.   

Abstract

In individuals with normal renal function, oral aluminum may be absorbed, but the kidneys are able to excrete the load, and significant pathology is not seen. If aluminum is given parenterally, however, it can accumulate in tissues and lead to osteomalacia or aplastic bone lesions. Low calcitriol and PTH levels are often seen, and may contribute to the bone disease. These findings in individuals with normal renal function add to the growing body of evidence that aluminum is toxic to bone.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3933333     DOI: 10.1016/s0272-6386(85)80082-2

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  4 in total

1.  Aluminium osteomalacia in chronic renal failure patients neither on dialysis nor taking aluminium containing phosphate binders.

Authors:  A A O'Brien; D P Moore; J A Keogh
Journal:  Ir J Med Sci       Date:  1990-03       Impact factor: 1.568

2.  Radiographic manifestations of experimental aluminum toxicity in growing bone.

Authors:  R J Hernandez; A B Sedman; D M Smid; W G Goodman
Journal:  Skeletal Radiol       Date:  1987       Impact factor: 2.199

Review 3.  Recent developments in aluminum toxicology.

Authors:  F S Monteagudo; M J Cassidy; P I Folb
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Jan-Feb

4.  No association between the aluminium content of trabecular bone and bone density, mass or size of the proximal femur in elderly men and women.

Authors:  Hans-Olov Hellström; Bengt Mjöberg; Hans Mallmin; Karl Michaëlsson
Journal:  BMC Musculoskelet Disord       Date:  2006-08-23       Impact factor: 2.362

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.